GGrantIndex
Sort

15,440 grants matching organoids

Oxylipin Signaling in Congenital Heart Disease

$480,038
Aitor Aguirre · Michigan State University · R01 · FY2021 · HL

The Development And Progression Of IPMN To PDA In The Context Of Inactivated Activin Signaling

$480,016
Gloria Huei-Ting Su · Columbia University Health Sciences · R01 · FY2021 · CA

Collaborative Research: RECODE: Directing and Controlling Cardiac Differentiation Through Cellular and Microenvironmental Manipulation and Application of Machine-Learning

$480,000
Sean M Wu · Stanford University · · FY2021 · ENG

Collective Gradient Sensing and Cell-to-Cell Variability - Theory and Experiment

$479,962
Brian Camley · Johns Hopkins University · · FY2020 · MPS

The Role of EBI3 in Regulating Gastritis and Gastric Carcinogenesis

$479,906
Richard J Dipaolo · Saint Louis University · R01 · FY2016 · DK

Project 2: Targeting STAT3 to Prevent Colorectal Cancer (CRC) in Hereditary Syndromes and Inflammatory Bowel Disease

$479,877
David John Tweardy · University Of Tx Md Anderson Can Ctr · P50 · FY2019 · CA

Variant-to-gene mapping for brain related traits and disorders

$479,827
Alessandra Chesi · University Of Pennsylvania · R35 · FY2022 · HG

Project-1: Comprehensive phenotypic and genetic assessment of TE birth defects in patients

$479,802
Wendy K Chung · Cincinnati Childrens Hosp Med Ctr · P01 · FY2024 · HD

Methionine and PI3K Metabolism Drive CIMP in EBV Epithelial Cancers

$479,777
Benjamin Elison Gewurz · Wistar Institute · P01 · FY2025 · CA

Epithelial interactions with indigenous and pathogenic microbes

$479,756
Vincent B Young · University Of Michigan At Ann Arbor · U19 · FY2018 · AI

Diet induced modifications of microbiota metabolites in colon tumorigenesis

$479,666
Robert Stephen Chapkin · Texas A&M Agrilife Research · R01 · FY2019 · CA

Induction of Vascular Morphogenesis

$479,566
Luisa Iruela-Arispe · University Of California Los Angeles · R01 · FY2013 · HL

Targeting oncogenic dopamine receptor signaling in glioblastoma

$479,545
Jeongwu Lee · Cleveland Clinic Lerner Com-Cwru · R01 · FY2020 · CA

Molecular Glues to Target RAS-MAPK Driven Cancers

$479,518
Arvin Dar · Sloan-Kettering Inst Can Research · R01 · FY2025 · CA

Molecular Basis of Human Visual System Disorders

$479,501
Rui Chen · Baylor College Of Medicine · R01 · FY2021 · EY

Molecular Basis of Human Visual System Disorders

$479,500
Rui Chen · Baylor College Of Medicine · R01 · FY2022 · EY

Determinants of immunotherapy response in NASH-Hepatocellular carcinoma

$479,492
Josep M Llovet · Icahn School Of Medicine At Mount Sinai · R01 · FY2025 · CA

Metabolic flux analysis and PDX models to understand therapeutic vulnerabilities following inhibition of Ref-1 redox signaling in pancreatic cancer

$479,470
Mark R. Kelley · Indiana University Indianapolis · R01 · FY2025 · CA

Drug Mechanism of Action-based targeting of tumor subpopulations

$479,435
Andrea Califano · Columbia University Health Sciences · U54 · FY2023 · CA

Project 2: Inhibition of RIPK1 Mediated Cell Death to Prevent GVHD

$479,401
James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2025 · CA

Project 2: Inhibition of RIPK1 Mediated Cell Death to Prevent GVHD

$479,401
James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2023 · CA

Project 2: Inhibition of RIPK1 Mediated Cell Death to Prevent GVHD

$479,401
James L M Ferrara · Icahn School Of Medicine At Mount Sinai · P01 · FY2022 · CA

Kinase Signaling in Epidermal Homeostasis and Early Neoplasia

$479,217
Carolyn S. Lee · Stanford University · R01 · FY2024 · CA

Lipid transport in the intestine

$479,192
Judith Storch · Rutgers, The State Univ Of N.J. · R01 · FY2023 · DK

Osteogenic Niche Biology in Progression and Endocrine Resistance of Bone Metastases

$479,104
David R Rowley · Baylor College Of Medicine · R01 · FY2022 · CA